Moderna Posts $1.2 Billion Loss as Demand For COVID Jab Collapses, Promises Investors ‘Next-Generation’ Vaccine to Tackle New Strains

The American drug company Moderna has posted a first-quarter loss of $1.2 billion after demand for their dodgy COVID-19 vaccine collapsed. The post Moderna Posts $1.2 Billion Loss as Demand For COVID Jab Collapses, Promises Investors ‘Next-Generation’ Vaccine to Tackle New Strains appeared first on The Gateway Pundit. Read More in The Gateway Pundit.   Read More in Red Pill NOWlej.